{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:41:12Z","timestamp":1794084072338,"version":"4.8.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100016239","name":"University of Occupational and Environmental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016239","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UOEH Grant for Advanced Research"},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"KAKENHI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Grant-in-Aid for Scientific Research","award":["#15K08790"],"award-info":[{"award-number":["#15K08790"]}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The presence of anti-U1 RNP antibodies (Abs) is critical for diagnosing MCTD. The aim of this study is to evaluate the clinical relevance of anti-survival motor neuron (SMN) complex Abs, which often coexist with anti-U1 RNP Abs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 158 newly diagnosed consecutive cases of SLE, SSc or MCTD with anti-U1 RNP Abs were enrolled in this multicentre observational study between April 2014 and August 2022. Serum anti-SMN complex Abs were screened by immunoprecipitation of 35S-methionine-labelled cell extracts, and associations between anti-SMN complex Abs positivity and clinical characteristics were analysed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Anti-SMN complex Abs were detected in 36% of MCTD patients, which was significantly higher than that in SLE (8%) or SSc (12%). Among MCTD patients classified based on the combination of the clinical features of SLE, SSc and idiopathic inflammatory myopathies, anti-SMN complex Abs showed the highest prevalence in a subset with clinical features of all three components. Anti-SMN complex Abs\u2013positive MCTD had a higher prevalence of pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD), which are related to poor prognosis, than negative patients. Moreover, all three cases of death within 1\u2009year of the treatment were positive for anti-SMN complex Abs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Anti-SMN complex Abs is the first biomarker of a typical subset of MCTD which bears organ damages such as PAH and ILD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/kead341","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T13:47:45Z","timestamp":1688824065000},"page":"1068-1075","source":"Crossref","is-referenced-by-count":9,"title":["Anti-survival motor neuron complex antibodies as a novel biomarker for pulmonary arterial hypertension and interstitial lung disease in mixed connective tissue disease"],"prefix":"10.1093","volume":"63","author":[{"given":"Yasuyuki","family":"Todoroki","sequence":"first","affiliation":[{"name":"First Department of Internal Medicine, University of Occupational and Environmental Health, Japan , Kitakyushu, Japan"},{"name":"Department of Molecular Targeted Therapies, School of Medicine, University of Occupational and Environmental Health, Japan , Kitakyushu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Satoh","sequence":"additional","affiliation":[{"name":"Department of Human, Information and Life Sciences, University of Occupational and Environmental Health, Japan , Kitakyushu, Japan"},{"name":"Department of Medicine, Kitakyushu Yahata-Higashi Hospital , Kitakyushu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9693-9263","authenticated-orcid":false,"given":"Satoshi","family":"Kubo","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, University of Occupational and Environmental Health, Japan , Kitakyushu, Japan"},{"name":"Department of Molecular Targeted Therapies, School of Medicine, University of Occupational and Environmental Health, Japan , Kitakyushu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6019-6784","authenticated-orcid":false,"given":"Shunpei","family":"Kosaka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kitakyushu General Hospital , Kitakyushu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Fukuyo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Wakamatsu Hospital of the University of Occupational and Environmental Health , Kitakyushu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Nakatsuka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Fukuoka Yutaka Central Hospital , Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tobata General Hospital , Kitakyushu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Human, Information and Life Sciences, University of Occupational and Environmental Health, Japan , Kitakyushu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Nakayamada","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, University of Occupational and Environmental Health, Japan , Kitakyushu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0807-7139","authenticated-orcid":false,"given":"Yoshiya","family":"Tanaka","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, University of Occupational and Environmental Health, Japan , Kitakyushu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,8]]},"reference":[{"key":"2024040216345242000_kead341-B1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41584-022-00845-w","article-title":"Precision medicine: the precision gap in rheumatic disease","volume":"18","author":"Lin","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2024040216345242000_kead341-B2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","article-title":"Mixed connective tissue disease\u2013an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)","volume":"52","author":"Sharp","year":"1972","journal-title":"Am J Med"},{"key":"2024040216345242000_kead341-B3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2169\/internalmedicine.38.386","article-title":"Mixed connective tissue disease","volume":"38","author":"Kasukawa","year":"1999","journal-title":"Intern Med"},{"key":"2024040216345242000_kead341-B4","doi-asserted-by":"crossref","first-page":"e000783","DOI":"10.1136\/rmdopen-2018-000783","article-title":"Mixed connective tissue disease: state of the art on clinical practice guidelines","volume":"4","author":"Chaigne","year":"2018","journal-title":"RMD Open"},{"key":"2024040216345242000_kead341-B5","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/rheumatology\/kes430","article-title":"Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature","volume":"52","author":"Gunnarsson","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"2024040216345242000_kead341-B6","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/1529-0131(199905)42:5<899::AID-ANR8>3.0.CO;2-L","article-title":"Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings","volume":"42","author":"Burdt","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2024040216345242000_kead341-B7","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1136\/annrheumdis-2011-201253","article-title":"Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study","volume":"71","author":"Gunnarsson","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2024040216345242000_kead341-B8","first-page":"648","article-title":"Interstitial lung disease in patients with mixed connective tissue disease: pilot study on predictors of lung involvement","volume":"36","author":"Narula","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2024040216345242000_kead341-B9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/rheumatology\/kex077","article-title":"Progression and mortality of interstitial lung disease in mixed connective tissue disease: a long-term observational nationwide cohort study","volume":"57","author":"Reiseter","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2024040216345242000_kead341-B10","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00296-018-4059-4","article-title":"The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease","volume":"38","author":"Dima","year":"2018","journal-title":"Rheumatol Int"},{"key":"2024040216345242000_kead341-B11","first-page":"2055","article-title":"Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse","volume":"23","author":"Amigues","year":"1996","journal-title":"J Rheumatol"},{"key":"2024040216345242000_kead341-B12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.semarthrit.2011.07.010","article-title":"\u201cTo be or not to be,\u201d ten years after: evidence for mixed connective tissue disease as a distinct entity","volume":"41","author":"Cappelli","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"2024040216345242000_kead341-B13","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/art.39432","article-title":"Characteristics and survival of anti-U1 RNP antibody-positive patients with connective tissue disease-associated pulmonary arterial hypertension","volume":"68","author":"Sobanski","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2024040216345242000_kead341-B14","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/art.30349","article-title":"Autoantibodies to survival of motor neuron complex in patients with polymyositis: immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins","volume":"63","author":"Satoh","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2024040216345242000_kead341-B15","doi-asserted-by":"crossref","first-page":"e001357","DOI":"10.1136\/rmdopen-2020-001357","article-title":"Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies","volume":"6","author":"Landon-Cardinal","year":"2020","journal-title":"RMD Open"},{"key":"2024040216345242000_kead341-B16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/rheumatology\/kex392","article-title":"Autoantibodies to the survival of motor neuron complex in a patient with necrotizing autoimmune myopathy","volume":"57","author":"Amlani","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2024040216345242000_kead341-B17","first-page":"139","author":"Satoh","year":"2014"},{"key":"2024040216345242000_kead341-B18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/14397595.2019.1709944","article-title":"2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases","volume":"31","author":"Tanaka","year":"2021","journal-title":"Mod Rheumatol"},{"key":"2024040216345242000_kead341-B19","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2024040216345242000_kead341-B20","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2024040216345242000_kead341-B21","doi-asserted-by":"crossref","first-page":"102458","DOI":"10.1016\/j.autrev.2020.102458","article-title":"Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud\u2019s phenomenon and systemic sclerosis","volume":"19","author":"Smith","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2024040216345242000_kead341-B22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41584-021-00685-0","article-title":"Detection of microvascular changes in systemic sclerosis and other rheumatic diseases","volume":"17","author":"Cutolo","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"2024040216345242000_kead341-B23","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1093\/rheumatology\/keac165","article-title":"Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD","volume":"61","author":"Todoroki","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2024040216345242000_kead341-B24","doi-asserted-by":"crossref","first-page":"e1802148","DOI":"10.1183\/13993003.02148-2018","article-title":"An overview of the 6th World Symposium on Pulmonary Hypertension","volume":"53","author":"Galie","year":"2019","journal-title":"Eur Respir J"},{"key":"2024040216345242000_kead341-B25","doi-asserted-by":"crossref","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J"},{"key":"2024040216345242000_kead341-B26","doi-asserted-by":"crossref","first-page":"11122","DOI":"10.1038\/s41598-022-15321-4","article-title":"Clinical characteristics of idiopathic interstitial pneumonias with anti-Ro52\/tripartite motif-containing 21 antibodies","volume":"12","author":"Tahara","year":"2022","journal-title":"Sci Rep"},{"key":"2024040216345242000_kead341-B27","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/art.22329","article-title":"Autoantibodies to RNA helicase A: a new serologic marker of early lupus","volume":"56","author":"Yamasaki","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2024040216345242000_kead341-B28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"2024040216345242000_kead341-B29","first-page":"275","author":"Satoh","year":"2011"},{"key":"2024040216345242000_kead341-B30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/rheumatology\/kev300","article-title":"Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease","volume":"55","author":"Gunnarsson","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2024040216345242000_kead341-B31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12016-011-8286-7","article-title":"Common pathways of autoimmune inflammatory myopathies and genetic neuromuscular disorders","volume":"42","author":"Satoh","year":"2012","journal-title":"Clin Rev Allergy Immunol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/kead341\/50950688\/kead341.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/4\/1068\/57140423\/kead341.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/4\/1068\/57140423\/kead341.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T18:23:54Z","timestamp":1712082234000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/4\/1068\/7221534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,8]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,7,8]]},"published-print":{"date-parts":[[2024,4,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead341","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4,1]]},"published":{"date-parts":[[2023,7,8]]}}}